Position in NVAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,149,121
-$3,343,721 QoQ
Shares Held
652,773
-44.0% QoQ
Ownership
0.396%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 263 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$942
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. NVAX ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in NVAX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $942 | 100 | Put | Other | 2026-08-13 | |
| 2026-06-30 | $6,149,121 | 652,773 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $814 | 100 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $9,492,842 | 1,166,197 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $814 | 100 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $6,246,985 | 929,611 | Shares | Other | 2026-02-13 | |
| 2025-12-31 | $2,688 | 400 | Put | Other | 2026-02-13 | |
| 2025-09-30 | $8,670 | 1,000 | Put | Other | 2025-11-13 | |
| 2025-09-30 | $438,658 | 50,595 | Shares | Other | 2025-11-13 | |
| 2024-09-30 | $1,880,821 | 148,917 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,591,655 | 362,690 | Shares | Other | 2024-08-14 | |
| 2022-06-30 | $8,236,874 | 160,157 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $1,219,202 | 16,554 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $6,522,704 | 45,591 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $3,287,936 | 15,860 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,684,540 | 40,905 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,202,932 | 50,758 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $320,814 | 2,877 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||